Clinical Trials
3 trialsNCT01444417 2017-02-09
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Amgen
Phase 3 Completed
NCT00515203 2014-07-25
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
Amgen
Phase 1/2 Completed
NCT00315419 2010-04-21
Identifying Characteristics of Bone Marrow Failure Syndromes
Office of Rare Diseases (ORD)
Unknown